{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:02:25Z","timestamp":1740142945475,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00508-020-01720-y","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T14:06:49Z","timestamp":1597068409000},"page":"284-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hydroxychloroquine versus lopinavir\/ritonavir in severe COVID-19 patients"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-2339","authenticated-orcid":false,"given":"Mario","family":"Karolyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0199-0539","authenticated-orcid":false,"given":"Erich","family":"Pawelka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Mader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Omid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Kelani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Ely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-7977","authenticated-orcid":false,"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Laferl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Traugott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wenisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Zoufaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"1720_CR1","unstructured":"ECDC. COVID-19 situation update worldwide, as of 22 July 2020. 2020. https:\/\/www.ecdc.europa.eu\/en\/geographical-distribution-2019-ncov-cases. Accessed: 30 June 2019."},{"key":"1720_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","author":"C Wu","year":"2020","unstructured":"Wu\u00a0C, Chen\u00a0X, Cai\u00a0Y, et\u00a0al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994.","journal-title":"JAMA Intern Med"},{"key":"1720_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","author":"F Zhou","year":"2020","unstructured":"Zhou\u00a0F, Yu\u00a0T, Du\u00a0R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a\u00a0retrospective cohort study. Lancet. 2020; https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet"},{"key":"1720_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","author":"WJ Guan","year":"2020","unstructured":"Guan\u00a0WJ, Ni\u00a0ZY, Hu\u00a0Y, et al. China medical treatment expert group for Covid-19. Clinical characteristics of Coronavirus disease 2019 in China. N\u00a0Engl J Med. 2020; https:\/\/doi.org\/10.1056\/NEJMoa2002032.","journal-title":"N Engl J Med"},{"key":"1720_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","author":"Z Wu","year":"2020","unstructured":"Wu\u00a0Z, McGoogan\u00a0JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China summary of a\u00a0report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020; https:\/\/doi.org\/10.1001\/jama.2020.2648.","journal-title":"JAMA"},{"key":"1720_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00547-2020","author":"W-J Guan","year":"2020","unstructured":"Guan\u00a0W\u2011J, Liang\u00a0W\u2011H, Zhao\u00a0Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir\u00a0J. 2020; https:\/\/doi.org\/10.1183\/13993003.00547-2020.","journal-title":"Eur Respir J"},{"key":"1720_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu\u00a0J, Cao\u00a0R, Xu\u00a0M, et al. Hydroxychloroquine, a\u00a0less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV\u20112 infection in vitro. Cell Discov. 2020;6:16.","journal-title":"Cell Discov"},{"key":"1720_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237","author":"X Yao","year":"2020","unstructured":"Yao\u00a0X, Ye\u00a0F, Zhang\u00a0M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-coV-2). Clin Infect Dis. 2020; https:\/\/doi.org\/10.1093\/cid\/ciaa237.","journal-title":"Clin Infect Dis"},{"key":"1720_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6019","author":"J Sanders","year":"2020","unstructured":"Sanders\u00a0J, Monogue\u00a0ML, Jodlowski\u00a0TZ, et al. Pharmacologic treatments for coronavirus disease 2019 (COVID-19). A review. JAMA. 2020; https:\/\/doi.org\/10.1001\/jama.2020.6019.","journal-title":"JAMA"},{"key":"1720_CR10","doi-asserted-by":"crossref","unstructured":"Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious diseases society of America Guidelines on the treatment and management of patients with COVID-19. IDSA guideline version 1.0.3. 2020. www.idsociety.org\/COVID19guidelines. Accessed: 5 May 2019.","DOI":"10.1093\/cid\/ciaa478"},{"key":"1720_CR11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282","author":"B Cao","year":"2020","unstructured":"Cao\u00a0B, Wang\u00a0Y, Wen\u00a0D, et al. A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19. N\u00a0Engl J Med. 2020; https:\/\/doi.org\/10.1056\/NEJMoa2001282.","journal-title":"N Engl J Med"},{"key":"1720_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","author":"P Gautret","year":"2020","unstructured":"Gautret\u00a0P, Lagier\u00a0JC, Parola\u00a0P, et al. Hydroxychloroquine and azithromycin as a\u00a0treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105949.","journal-title":"Int J Antimicrob Agents"},{"key":"1720_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101663","author":"P Gautret","year":"2020","unstructured":"Gautret\u00a0P, Lagier\u00a0JC, Parola\u00a0P, et al. Clinical and microbiological effect of a\u00a0combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a\u00a0six-day follow up: an observational study. Travel Med Infect Dis. 2020; https:\/\/doi.org\/10.1016\/j.tmaid.2020.101663.","journal-title":"Travel Med Infect Dis"},{"key":"1720_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.22.20040758","author":"Z Chen","year":"2020","unstructured":"Chen\u00a0Z, Hu\u00a0J, Zhang\u00a0Z, et al. Efficacy of hydroxychloroquine in patients with COVID-19: results of a\u00a0randomized clinical trial. medRxiv. 2020; https:\/\/doi.org\/10.1101\/2020.03.22.20040758.","journal-title":"medRxiv"},{"key":"1720_CR15","doi-asserted-by":"publisher","DOI":"10.3785\/j.issn.1008-9292.2020.03.03","author":"J Chen","year":"2020","unstructured":"Chen\u00a0J, Liu\u00a0D, Liu\u00a0L, et al. A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19). J\u00a0Zhejiang Univ (Med Sci). 2020; https:\/\/doi.org\/10.3785\/j.issn.1008-9292.2020.03.03.","journal-title":"J Zhejiang Univ (Med Sci)"},{"key":"1720_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.10.20060558","author":"W Tang","year":"2020","unstructured":"Tang\u00a0W, Cao\u00a0Z, Han\u00a0M, et al. Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial. medRxiv. 2020; https:\/\/doi.org\/10.1101\/2020.04.10.20060558.","journal-title":"medRxiv"},{"key":"1720_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.16.20065920","author":"J Magagnoli","year":"2020","unstructured":"Magagnoli\u00a0J, Narendran\u00a0S, Pereira\u00a0F, et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv. 2020; https:\/\/doi.org\/10.1101\/2020.04.16.20065920.","journal-title":"medRxiv"},{"key":"1720_CR18","unstructured":"WHO. \u201cSolidarity\u201d clinical trial for COVID-19 treatments. 2020. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments. Accessed: 5 May 2019."},{"key":"1720_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25729","author":"TT Yao","year":"2020","unstructured":"Yao\u00a0TT, Qian\u00a0JD, Zhu\u00a0WY, et al. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus\u2014A possible reference for coronavirus disease-19 treatment option. J\u00a0Med Virol. 2020; https:\/\/doi.org\/10.1002\/jmv.25729.","journal-title":"J Med Virol"},{"issue":"(6","key":"1720_CR20","first-page":"399","volume":"9","author":"KS Chan","year":"2003","unstructured":"Chan\u00a0KS, Lai\u00a0ST, Chu\u00a0CM, et\u00a0al. Treatment of severe acute respiratory syndrome with lopinavir\/ritonavir: a\u00a0multicentre retrospective matched cohort study. Hong Kong Med\u00a0J. 2003;9((6):399\u2013406.","journal-title":"Hong Kong Med J"},{"issue":"1","key":"1720_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/cid\/ciy860","volume":"69","author":"J Katzen","year":"2019","unstructured":"Katzen\u00a0J, Kohn\u00a0R, Houk\u00a0J, et al. Early oseltamivir after hospital admission is associated with shortened hospitalization: a five-year analysis of oseltamivir timing and clinical outcomes. Clin Infect Dis. 2019;69(1):52\u20138. https:\/\/doi.org\/10.1093\/cid\/ciy860.","journal-title":"Clin Infect Dis"},{"key":"1720_CR22","doi-asserted-by":"publisher","DOI":"10.2900\/01723","volume-title":"Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza\u2014Review of recent systematic reviews and meta-analyses","author":"European Centre for Disease Prevention and Control","year":"2017","unstructured":"European Centre for Disease Prevention and Control. Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza\u2014Review of recent systematic reviews and meta-analyses. Stockholm: ECDC; 2017. https:\/\/doi.org\/10.2900\/01723."},{"issue":"6","key":"1720_CR23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy866","volume":"68","author":"TM Uyeki","year":"2019","unstructured":"Uyeki\u00a0TM, Bernstein\u00a0HH, Bradley\u00a0JS, et\u00a0al. Clinical practice guidelines by the infectious diseases society of america: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68(6):e1\u201347.","journal-title":"Clin Infect Dis"},{"key":"1720_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa351","author":"K Xu","year":"2020","unstructured":"Xu\u00a0K, Chen\u00a0Y, Yuan\u00a0J, et al. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clin Infect Dis. 2020; https:\/\/doi.org\/10.1093\/cid\/ciaa351.","journal-title":"Clin Infect Dis"},{"key":"1720_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa451","author":"B Zhou","year":"2020","unstructured":"Zhou\u00a0B, She\u00a0J, Wang\u00a0Y, et al. The duration of viral shedding of discharged patients with severe COVID-19. Clin Infect Dis. 2020; https:\/\/doi.org\/10.1093\/cid\/ciaa451.","journal-title":"Clin Infect Dis"},{"key":"1720_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2196-x","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel\u00a0R, Corman\u00a0VM, Guggemos\u00a0W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; https:\/\/doi.org\/10.1038\/s41586-020-2196-x.","journal-title":"Nature"},{"key":"1720_CR27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012410","author":"J Geleris","year":"2020","unstructured":"Geleris\u00a0J, Sun\u00a0Y, Platt\u00a0J, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N\u00a0Eng J Med. 2020; https:\/\/doi.org\/10.1056\/NEJMoa2012410.","journal-title":"N Eng J Med"},{"key":"1720_CR28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8630","author":"E Rosenberg","year":"2020","unstructured":"Rosenberg\u00a0E, Dufort\u00a0E, Udo\u00a0T, et al. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state. JAMA. 2020; https:\/\/doi.org\/10.1001\/jama.2020.8630.","journal-title":"JAMA"},{"issue":"10238","key":"1720_CR29","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","volume":"395","author":"IF Hung","year":"2020","unstructured":"Hung\u00a0IF, Lung\u00a0KC, Tso\u00a0EY, et al. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020;395(10238):1695\u2013704. https:\/\/doi.org\/10.1016\/S0140-6736(20)31042-4.","journal-title":"Lancet"},{"key":"1720_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa638","author":"J Bullard","year":"2020","unstructured":"Bullard\u00a0J, Dust\u00a0K, Funk\u00a0D, et al. Predicting infectious SARS-CoV\u20112 from diagnostic samples. Clin Infect Dis. 2020; https:\/\/doi.org\/10.1093\/cid\/ciaa638.","journal-title":"Clin Infect Dis"},{"key":"1720_CR31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","author":"JH Beigel","year":"2020","unstructured":"Beigel\u00a0JH, Tomashek\u00a0KM, Dodd\u00a0LE, et al. Remdesivir for the treatment of Covid-19\u2014Preliminary Report. N\u00a0Engl J Med. 2020; https:\/\/doi.org\/10.1056\/NEJMoa2007764.","journal-title":"N Engl J Med"},{"key":"1720_CR32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015301","author":"JD Goldman","year":"2020","unstructured":"Goldman\u00a0JD, Lye\u00a0DCB, Hui\u00a0DS, et al. Remdesivir for 5 or 10 days in patients with severe Covid-19. n Engl J Med. 2020; https:\/\/doi.org\/10.1056\/NEJMoa2015301.","journal-title":"n Engl J Med"},{"key":"1720_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.22.20137273","author":"P Horby","year":"2020","unstructured":"Horby\u00a0P, Lim\u00a0WS, Emberson\u00a0J, et al. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv. 2020; https:\/\/doi.org\/10.1101\/2020.06.22.20137273.","journal-title":"medRxiv"},{"key":"1720_CR34","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1550","author":"C Sch\u00f6rgenhofer","year":"2020","unstructured":"Sch\u00f6rgenhofer\u00a0C, Jilma\u00a0B, Stimpfl\u00a0T, et al. Pharmacokinetics of lopinavir and ritonavir in patients hospitalized with coronavirus disease 2019 (COVID-19). Ann Intern Med. 2020; https:\/\/doi.org\/10.7326\/M20-1550.","journal-title":"Ann Intern Med"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-020-01720-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:13:33Z","timestamp":1628550813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-020-01720-y"}},"subtitle":["Results from a\u00a0real-life patient cohort"],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":34,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1007\/s00508-020-01720-y","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"type":"print","value":"0043-5325"},{"type":"electronic","value":"1613-7671"}],"subject":[],"published":{"date-parts":[[2020,8,10]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Karolyi, E.\u00a0Pawelka, T.\u00a0Mader, S.\u00a0Omid, H.\u00a0Kelani, S.\u00a0Ely, B.\u00a0Jilma, S.\u00a0Baumgartner, H.\u00a0Laferl, C.\u00a0Ott, M.\u00a0Traugott, M.\u00a0Turner, T.\u00a0Seitz, C.\u00a0Wenisch, and A.\u00a0Zoufaly declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}